Operational planning and early cost analyses are key to generating optimal, robust, and economical commercial processes.
The authors describe a novel means to control ice nucleation using a sterile cryogenic ice fog.
The authors describe a simple method to remove endotoxins from highly viscous formulations.
A novel approach to sterile drug product manufacturing uses a single-use assembly in a multi-product final filling suite with isolator technology.
Webinar Date/Time: Thu, Sep 5, 2024 11:00 AM EDT
Reauthorization of pediatric exclusivity provisions looms in 2012 and debates begin anew.
The Madrid Protocol offers companies another option for trademark registration on a global scale.
Chromatography modeling can enhance bioprocessing efficiencies.
Partnering with CDMOs can help bridge the innovation gap.
Molecular mimicry is a common, but undesirable, property of disease proteins. Sequence similarities between cancer proteins and self-proteins allow tumor cells to hide, thereby avoiding attack from the immune system. HIV uses the same evasive tactic.
Creation and qualification of scale-down models is essential for performing several critical activities that support process validation and commercial manufacturing. This combined article is the fifth in the "Elements of Biopharmaceutical Production" series. Part 1 (March 2005) covered fermentation. In this segment, we present some guidelines and examples for scale-down of common downstream unit operations used in biotech processes - chromatography and filtration.
New technology is designed to improve production efficiency by taking advantage of the properties of single-use bags.
The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.
A perspective on why platform processes are not and should not define the future of bioprocess development efforts. This article is part of a special section on biopharmaceutical trends.
This technology includes an efficient and scalable in vitro enzymatic amidation step for peptide hormones.
Unnecessary analytical testing can lead to unnecessary costs.
This study on a recombinant human follicle stimulating hormone demonstrates the use of virus filters to reduce the risk of contamination.
By embracing efficiency and quality, biopharmaceutical organizations can work better and achieve better work.
Big Pharma execs bring to biotech the knowledge of what it takes to make something a commercial success-not getting to market, but to Phase I.
New research shows KLEPTOSE® BIOPHARMA as a potential functional alternative to surfactants within biologic formulations, learn more from Roquette’s experts Peter Ferguson and Pen Tao. Live: Tuesday, Oct. 29, 2019 at 9am CDT | 10am EDT | 2pm GMT | 3pm CET On demand available after airing until Oct. 29, 2020 Register free
Can a nanofiltration process be leveraged for removal of prions?